Results 31 to 40 of about 8,397 (218)

Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. [PDF]

, 2007
BACKGROUND: Although Kabul city, Afghanistan, is currently the worldwide largest focus of cutaneous leishmaniasis (CL) with an estimated 67,500 cases, donor interest in CL has been comparatively poor because the disease is non-fatal. Since 1998 HealthNet
Reithinger, Richard, Coleman, Paul G, Reithinger Richard, Richard Reithinger, Coleman Paul G, Paul G Coleman   +5 more
core   +1 more source

Assessment of Leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993. [PDF]

, 2001
Using a capture-recapture method, this study evaluates the completeness of the cutaneous leishmaniasis (CL) surveillance system in four districts of Santiago del Estero province, Argentina, for the period 1990-1993. Four reporting sources were evaluated:
Yadón, ZE, E L Segura, Z E Yadón, Yadón, Zaida E., L C Rodrigues, Quigley, MA, Davies, CR, Rodrigues, LC, C R Davies, Segura, Elsa L., Segura, Elsa Leonor, Quigley, Maria A., Quigley, Maria, M A Quigley, Rodrigues, Laura C., Davies, Clive R., Segura, EL   +16 more
core   +1 more source

The transmission dynamics of canine American cutaneous leishmaniasis in Huánuco, Peru. [PDF]

, 2003
The epidemiology of canine American cutaneous leishmaniasis (ACL) due to Leishmania (Viannia) spp. was investigated in Huánuco, Peru to 1) describe the natural course of canine L.
Reithinger, Richard, Espinoza, Juan Canales, Davies, Clive R   +2 more
core   +1 more source

Treatment of leishmaniasis with chemotherapy and vaccine: a mathematical model

Journal of Biological Dynamics, 2023
Leishmaniasis, an infectious disease, manifests itself mostly in two forms, cutaneous leishmaniasis (CL) and, a more severe and potentially deadly form, visceral leishmaniasis (VL).
Nourridine Siewe, Avner Friedman
doaj   +1 more source

Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites

Frontiers in Cellular and Infection Microbiology, 2022
In human cutaneous leishmaniasis (HCL) caused by Leishmania (L.) major, the cutaneous lesions heal spontaneously and induce a Th1-type immunity that confers solid protection against reinfection.
Rabiaa M. Sghaier, Rabiaa M. Sghaier, Fouad Benhnini, Fouad Benhnini, Fatma Z. Guerfali, Fatma Z. Guerfali, Hanène Attia, Hanène Attia, Aymen Bali, Aymen Bali, Amor Zaatour, Amor Zaatour, Amor Zaatour, Ghada Mkannez, Ghada Mkannez, Adel Gharbi, Adel Gharbi, Adel Gharbi, Nabil Belhaj-Hamida, Nabil Belhaj-Hamida, Nabil Belhaj-Hamida, Hichem Dridi, Hichem Dridi, Hichem Dridi, Afif Ben-Salah, Afif Ben-Salah, Afif Ben-Salah, Afif Ben-Salah, Koussay Dellagi, Koussay Dellagi, Dhafer Laouini, Dhafer Laouini   +31 more
doaj   +1 more source

Multiple hybrid genotypes of Leishmania (viannia) in a focus of mucocutaneous Leishmaniasis. [PDF]

, 2007
The principal agent of mucocutaneous leishmaniasis (MCL) is the South American protozoan parasite Leishmania (Viannia) braziliensis. This organism is generally considered to be clonal, that is, it does not to undergo genetic exchange.
Miles, Michael A, Roncal, Norma, Nolder, Debbie, Llanos-Cuentas, Alejandro, Davies, Clive R   +4 more
core   +1 more source

Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. [PDF]

PLoS Neglected Tropical Diseases, 2014
BACKGROUND: Leishmaniasis remains a worldwide public health problem. The limited therapeutic options, drug toxicity and reports of resistance, reinforce the need for the development of new treatment options.
Diego M Santos, Antonio L O A Petersen, Fabiana S Celes, Valeria M Borges, Patricia S T Veras, Camila I de Oliveira   +5 more
doaj   +1 more source

Protective Immunity and Vaccination Against Cutaneous Leishmaniasis

Frontiers in Immunology, 2012
Although a great deal of knowledge has been gained from studies on the immunobiology of leishmaniasis, there is still no effective vaccine against the disease.
Ifeoma eOkwor, Zhirong eMou, Liu eDong, JUDE EZEH UZONNA, JUDE EZEH UZONNA   +4 more
doaj   +1 more source

Combination Therapy with Tamoxifen and Amphotericin B in Experimental Cutaneous Leishmaniasis [PDF]

Antimicrobial Agents and Chemotherapy, 2014
ABSTRACTLeishmaniasis chemotherapy remains very challenging. The high cost of active drugs, along with the severity of their side effects and the increasing failure rate of the current therapeutic schemes, calls for the discovery of new active drugs and schemes of treatment.
Cristiana T, Trinconi, Juliana Q, Reimão, Jenicer K U, Yokoyama-Yasunaka, Danilo C, Miguel, Silvia R B, Uliana   +4 more
openaire   +2 more sources

The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: 'bringing down the neighbourhood'. [PDF]

, 2003
In order to investigate the distribution and causes of the spread of anthroponotic cutaneous leishmaniasis (ACL) in Kabul, Afghanistan, a cross-sectional study was conducted during 1997-98 amongst 75,787 residents in the 13 central districts of the city.
Rowland, Mark, Davies, Clive, Khan, Bismulla, Reyburn, Hugh, Mohsen, Mohammmed   +4 more
core   +1 more source